# RVMDW (Revolution Medicines, Inc.) - SEC EDGAR Financial Statements

> Revolution Medicines, Inc. reported $0 in revenue and a net loss of $1.87B for the fiscal year ended December 31, 2025.

- Canonical: https://convexityos.com/fundamentals/RVMDW
- Markdown: https://convexityos.com/fundamentals/RVMDW.md
- SEC CIK: 0001628171
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:03 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001628171&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | Dec 31, 2025 |
| Operating Income | FY 2025 | -$1.69B | Operating profit |
| Net Income | FY 2025 | -$1.87B | GAAP bottom line |
| Diluted EPS | FY 2025 | -$8.70 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$1.44B | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $3.65B | Total debt: $151.2M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $11.58M | $35.38M | $29.39M | $42.98M | $50.04M | $20.16M |
| Research & Development | $987.3M | $592.2M | $423.1M | $253.1M | $186.9M | $132.3M | $91.75M | $51.08M |
| Total Operating Expenses | $1.18B | $689.5M | $498.8M | $293.7M | $217.4M | $153.7M | $104.2M | $60.49M |
| **Operating Income** | -$1.18B | -$689.5M | -$487.2M | -$258.3M | -$188.0M | -$110.7M | -$54.12M | -$40.33M |
| **EBITDA** | -$1.17B | -$683.0M | -$482.1M | -$254.3M | -$184.9M | -$108.1M | -$51.85M | -$38.76M |
| Interest Income | $90.69M | $86.88M | $47.48M | $9.15M | $929K | $2.24M | $2.19M | $777K |
| Interest Expense | $24.23M | $0 | $0 | $0 | $12K | $71K | $106K | $116K |
| Income Before Tax | -$1.13B | -$600.8M | -$439.9M | -$249.1M | -$187.1M | -$108.5M | -$52.04M | -$41.79M |
| Income Tax Expense | $0 | -$753K | -$3.52M | -$420K | $0 | -$371K | -$4.37M | -- |
| **Net Income** | -$1.13B | -$600.1M | -$436.4M | -$248.7M | -$187.1M | -$108.2M | -$47.66M | -$41.79M |
| Basic EPS | -$5.95 | -$3.58 | -$3.86 | -$3.08 | -$2.57 | -$2.01 | -$22.33 | -$21.24 |
| **Diluted EPS** | -$5.95 | -$3.58 | -$3.86 | -$3.08 | -$2.57 | -$2.01 | -$22.33 | -$21.24 |
| Basic Shares Outstanding | 190.1M | 167.7M | 113.1M | 80.6M | 72.8M | 54.9M | 2.8M | 2.3M |
| Diluted Shares Outstanding | 190.1M | 167.7M | 113.1M | 80.6M | 72.8M | 54.9M | 2.8M | 2.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $197.6M | -- | -- | -- | $0 | -- | -- | $0 |
| Cost of Revenue | $327K | -- | -- | -- | $0 | -- | -- | -- |
| **Gross Profit** | $197.2M | -- | -- | -- | $0 | -- | -- | -- |
| Research & Development | $417.1M | $394.9M | $344.0M | $294.9M | $262.5M | $224.1M | $205.7M | $188.1M |
| Selling, General & Admin | $153.3M | -- | -- | -- | $52.76M | -- | -- | -- |
| Total Operating Expenses | -- | $505.1M | $445.2M | $361.6M | $315.3M | $264.7M | $240.8M | $216.3M |
| **Operating Income** | -$373.1M | -$505.1M | -$445.2M | -$361.6M | -$315.3M | -$264.7M | -$240.8M | -$216.3M |
| **EBITDA** | -$370.5M | -$502.7M | -$442.9M | -$359.4M | -$313.7M | -$262.4M | -$239.1M | -$214.6M |
| Interest Income | $37.78M | $35.58M | $19.51M | $21.29M | $22.08M | $22.40M | $24.91M | $21.23M |
| Interest Expense | $33.80M | $23.78M | $12.20M | $11.94M | $11.43M | $867K | $0 | -- |
| Income Before Tax | -$409.8M | -$644.4M | -$453.8M | -$364.9M | -$305.2M | -$247.8M | -$213.4M | -$195.3M |
| Income Tax Expense | -$2.35M | -- | -- | -- | $0 | -- | -- | -$753K |
| **Net Income** | -$407.5M | -$644.4M | -$453.8M | -$364.9M | -$305.2M | -$247.8M | -$213.4M | -$194.6M |
| Basic EPS | -$1.90 | -$3.06 | -$2.29 | -- | -$1.61 | -$1.31 | -$1.13 | -- |
| **Diluted EPS** | -$1.90 | -$3.06 | -$2.29 | -- | -$1.61 | -$1.31 | -$1.13 | -- |
| Basic Shares Outstanding | 214.9M | 210.9M | 198.1M | -- | 189.2M | 188.6M | 188.1M | -- |
| Diluted Shares Outstanding | 214.9M | 210.9M | 198.1M | -- | 189.2M | 188.6M | 188.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $383.7M | $543.1M | $696.1M | $161.4M | $108.5M | $104.3M | $16.66M |
| Short-Term Investments | $1.64B | $1.75B | $1.16B | $483.5M | $468.6M | $336.5M | $106.1M |
| **Cash & Short-Term Investments** | $2.03B | $2.29B | $1.85B | $644.9M | $577.1M | $440.7M | $122.8M |
| Accounts Receivable, Net | $0 | -- | -- | -- | -- | -- | -- |
| Inventory | $0 | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $2.08B | $2.33B | $1.88B | $660.2M | $589.8M | $454.1M | $134.0M |
| Property, Plant & Equipment, Net | $33.19M | $24.29M | $22.86M | $18.66M | $11.54M | $8.90M | $7.15M |
| Goodwill | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M |
| Intangible Assets | $55.80M | $56.67M | $57.74M | $58.81M | $59.88M | $60.95M | $62.01M |
| Other Non-Current Assets | $14.78M | $1.74M | $7.03M | $2.86M | $758K | $305K | $2.57M |
| **Total Non-Current Assets** | $279.5M | $230.7M | $182.4M | $151.7M | $148.2M | $113.3M | $86.55M |
| **Total Assets** | $2.35B | $2.56B | $2.06B | $811.9M | $738.0M | $567.4M | $220.5M |
| Accounts Payable | $64.62M | $54.43M | $61.79M | $21.31M | $14.06M | $12.61M | $11.40M |
| Deferred Revenue (Current) | -- | -- | $0 | $4.46M | $12.36M | $12.11M | -- |
| Other Current Liabilities | $7.86M | $583K | $3.90M | $505K | $311K | $97K | $1.05M |
| **Total Current Liabilities** | $290.4M | $163.9M | $143.9M | $61.98M | $60.35M | $47.18M | $43.05M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $6.57M | $8.48M | -- |
| Other Non-Current Liabilities | $1.21M | $670K | $1.46M | $301K | $634K | $632K | $655K |
| **Total Non-Current Liabilities** | $432.8M | $129.2M | $91.66M | $64.76M | $75.07M | $45.55M | $24.94M |
| **Total Liabilities** | $723.2M | $293.1M | $235.5M | $126.7M | $135.4M | $92.72M | $67.99M |
| **Total Debt (incl. Leases)** | $158.7M | $135.8M | $87.94M | $64.20M | $66.63M | $32.68M | $172K |
| Common Stock | $19K | $18K | $16K | $9.0K | $8.0K | $7.0K | -- |
| Retained Earnings | -$2.87B | -$1.74B | -$1.14B | -$701.3M | -$452.6M | -$265.5M | -$157.4M |
| Accumulated Other Comp. Income | $3.24M | $1.32M | $544K | -$1.78M | -$376K | $116K | $74K |
| **Total Stockholders' Equity** | $1.63B | $2.27B | $1.83B | $685.2M | $602.6M | $474.7M | -$152.6M |
| Total Equity | $1.63B | $2.27B | $1.83B | $685.2M | $602.6M | $474.7M | -$152.6M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $615.9M | $815.4M | $440.9M | $383.7M | $217.4M | $402.4M | $333.6M | $543.1M |
| Short-Term Investments | $3.04B | $3.12B | $1.47B | $1.64B | $1.71B | $1.73B | $1.77B | $1.75B |
| **Cash & Short-Term Investments** | $3.65B | $3.94B | $1.91B | $2.03B | $1.93B | $2.14B | $2.10B | $2.29B |
| Accounts Receivable, Net | $230.7M | -- | -- | $0 | -- | -- | -- | -- |
| Inventory | $11.02M | -- | -- | $0 | -- | -- | -- | -- |
| **Total Current Assets** | $3.98B | $4.03B | $1.97B | $2.08B | $1.98B | $2.18B | $2.13B | $2.33B |
| Property, Plant & Equipment, Net | $34.63M | $34.61M | $31.48M | $33.19M | $32.93M | $33.05M | $27.15M | $24.29M |
| Goodwill | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M |
| Intangible Assets | $55.47M | $55.80M | $55.80M | $55.80M | $55.87M | $56.14M | $56.40M | $56.67M |
| Other Non-Current Assets | $15.23M | $14.76M | $14.48M | $14.78M | $14.87M | $31.42M | $13.13M | $1.74M |
| **Total Non-Current Assets** | $326.8M | $294.9M | $285.8M | $279.5M | $274.4M | $253.1M | $230.8M | $230.7M |
| **Total Assets** | $4.30B | $4.32B | $2.25B | $2.35B | $2.25B | $2.43B | $2.37B | $2.56B |
| Accounts Payable | $100.7M | $88.42M | $80.54M | $64.62M | $74.85M | $56.76M | $47.51M | $54.43M |
| Other Current Liabilities | $22.73M | $5.14M | $3.26M | $7.86M | $8.24M | $462K | $651K | $583K |
| **Total Current Liabilities** | $475.7M | $354.1M | $289.6M | $290.4M | $245.6M | $184.5M | $158.6M | $163.9M |
| Other Non-Current Liabilities | $0 | $1.65M | $6.88M | $1.21M | $2.48M | $7.20M | $4.14M | $670K |
| **Total Non-Current Liabilities** | $1.43B | $1.36B | $464.2M | $432.8M | $409.4M | $379.7M | $128.6M | $129.2M |
| **Total Liabilities** | $1.90B | $1.72B | $753.8M | $723.2M | $655.0M | $564.2M | $287.2M | $293.1M |
| **Total Debt (incl. Leases)** | $151.2M | $154.5M | $156.6M | $158.7M | $158.5M | $132.8M | $134.3M | $135.8M |
| Common Stock | $22K | $21K | $19K | $19K | $18K | $18K | $18K | $18K |
| Retained Earnings | -$4.37B | -$3.97B | -$3.32B | -$2.87B | -$2.50B | -$2.20B | -$1.95B | -$1.74B |
| Accumulated Other Comp. Income | -$14.67M | -$5.95M | -$622K | $3.24M | $3.12M | $1.30M | $1.71M | $1.32M |
| **Total Stockholders' Equity** | $2.40B | $2.61B | $1.50B | $1.63B | $1.60B | $1.87B | $2.08B | $2.27B |
| Total Equity | $2.40B | $2.61B | $1.50B | $1.63B | $1.60B | $1.87B | $2.08B | $2.27B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.13B | -$600.1M | -$436.4M | -$248.7M | -$187.1M | -$108.2M | -$47.66M | -$41.79M |
| Depreciation & Amortization | $7.78M | $6.56M | $5.04M | $3.97M | $3.08M | $2.61M | $2.27M | $1.57M |
| Stock-Based Compensation | $118.4M | $79.20M | $61.77M | $31.20M | $20.72M | $8.89M | $3.16M | $855K |
| Change in Receivables | $0 | $1.25M | $3.42M | $1.26M | $464K | $2.34M | -$1.43M | -- |
| Change in Payables | $9.54M | -$6.46M | $32.47M | $7.29M | $2.24M | $305K | $5.26M | $109K |
| **Operating Cash Flow** | -$897.7M | -$557.4M | -$350.6M | -$224.4M | -$147.2M | -$100.1M | -$49.62M | $1.21M |
| Capital Expenditure | -$15.99M | -$10.31M | -$7.73M | -$10.82M | -$6.53M | -$2.93M | -$2.59M | -$1.50M |
| **Free Cash Flow** | -$913.7M | -$567.7M | -$358.3M | -$235.2M | -$153.7M | -$103.0M | -$52.20M | -$286K |
| Purchases of Investments | -$1.79B | -$2.14B | -$1.06B | -$612.8M | -$671.3M | -$544.1M | -$172.3M | -- |
| **Investing Cash Flow** | $118.1M | -$554.4M | -$342.6M | -$24.12M | -$142.1M | -$234.2M | -$102.0M | -$1.34M |
| Common Stock Issued | $0 | $727.6M | $323.7M | $248.1M | $281.1M | $420.1M | -- | -- |
| Dividends Paid | -- | -- | -- | -- | -- | $0 | -- | -- |
| **Financing Cash Flow** | $621.5M | $959.4M | $1.23B | $301.4M | $294.2M | $422.8M | $98.66M | $60.85M |
| **Net Change in Cash** | -$158.2M | -$152.4M | $536.0M | $52.91M | $4.88M | $88.48M | -$52.93M | $60.72M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$407.5M | -$644.4M | -$453.8M | -$364.9M | -$305.2M | -$247.8M | -$213.4M | -$194.6M |
| Depreciation & Amortization | $2.63M | $2.45M | $2.35M | $2.27M | $1.53M | $2.29M | $1.69M | $1.74M |
| Stock-Based Compensation | $62.63M | $67.00M | $87.30M | $33.70M | $30.78M | $28.83M | $25.08M | $22.44M |
| Change in Receivables | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| Change in Payables | $13.80M | $5.03M | $16.86M | -$10.50M | $19.55M | $8.76M | -$8.27M | $29.36M |
| **Operating Cash Flow** | -$415.6M | -$387.3M | -$354.2M | -$274.2M | -$207.3M | -$221.8M | -$194.4M | -$138.3M |
| Capital Expenditure | -$3.70M | -$2.29M | -$1.54M | -$1.93M | -$3.35M | -$7.45M | -$3.27M | -$1.22M |
| **Free Cash Flow** | -$419.3M | -$389.6M | -$355.7M | -$276.2M | -$210.7M | -$229.2M | -$197.7M | -$139.5M |
| Purchases of Investments | -$540.7M | -$2.04B | -$209.7M | -$296.5M | -$459.0M | -$529.3M | -$510.0M | -$695.2M |
| **Investing Cash Flow** | $80.10M | -$1.66B | $172.6M | $74.88M | $24.85M | $34.28M | -$15.95M | -$392.9M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $727.6M |
| **Financing Cash Flow** | $147.0M | $2.42B | $238.7M | $365.7M | -$1.59M | $256.6M | $874K | $873.8M |
| **Net Change in Cash** | -$188.6M | $374.5M | $57.19M | $166.3M | -$184.1M | $69.10M | -$209.5M | $342.6M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -4207.1% | -730.0% | -639.7% | -257.5% | -108.2% | -200.0% |
| **Net Profit Margin** | -- | -- | -3768.3% | -703.0% | -636.6% | -251.6% | -95.2% | -207.2% |
| Return on Equity (ROE) | -69.3% | -26.5% | -23.9% | -36.3% | -31.0% | -22.8% | -- | -- |
| Return on Assets (ROA) | -48.0% | -23.5% | -21.2% | -30.6% | -25.4% | -19.1% | -21.6% | -- |
| Current Ratio | 7.14x | 14.20x | 13.06x | 10.65x | 9.77x | 9.63x | 3.11x | -- |
| Quick Ratio | 7.14x | 13.97x | 12.88x | 10.40x | 9.56x | 9.34x | 2.85x | -- |
| Debt to Equity | 0.10x | 0.06x | 0.05x | 0.09x | 0.11x | 0.07x | -- | -- |
| **Revenue Growth (YoY)** | -- | -100.0% | -67.3% | +20.4% | -31.6% | -14.1% | +148.2% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -4190.4% | -- |
| 5Y Revenue / Share Growth | -100.0% | -100.0% | -98.8% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -77.9% | -67.8% | -91.5% | -69.3% | -60.2% | -43.5% | -33.6% | -26.5% |
| Return on Assets (ROA) | -43.5% | -40.9% | -60.9% | -48.0% | -42.7% | -33.4% | -29.5% | -23.5% |
| Current Ratio | 8.36x | 11.38x | 6.80x | 7.14x | 8.05x | 11.79x | 13.46x | 14.20x |
| Quick Ratio | 8.34x | 11.12x | 6.59x | 7.14x | 7.86x | 11.58x | 13.26x | 13.97x |
| Debt to Equity | 0.06x | 0.06x | 0.10x | 0.10x | 0.10x | 0.07x | 0.06x | 0.06x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -100.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
